|
1
|
Njei B, Rotman Y, Ditah I and Lim JK:
Emerging trends in hepatocellular carcinoma incidence and
mortality. Hepatology. 61:191–199. 2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Global Burden of Disease Liver Cancer
Collaboration. Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu
MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, et al: The
burden of primary liver cancer and underlying etiologies from 1990
to 2015 at the global, regional, and national level: Results from
the Global Burden of Disease Study. JAMA Oncol. 3:1683–1691.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Qian X, Yan X, Zhai X, Li N, Qu C and Lu
F: Hepatocellular carcinoma surveillance and treatment: A way to
reduce cancer-related mortality in cirrhotic patients. J Clin
Transl Hepatol. 7:1–2. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Berkel C and Cacan E: DYNLL1 is
hypomethylated and up-regulated in a tumor stage- and
grade-dependent manner and associated with increased mortality in
hepatocellular carcinoma. Exp Mol Pathol.
117(104567)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Wang M, Gu B, Yao G, Li P and Wang K:
Circular RNA expression profiles and the Pro-tumorigenic function
of CircRNA_10156 in Hepatitis B Virus-related liver cancer. Int J
Med Sci. 17:1351–1365. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Banaudha KK and Verma M: Epigenetic
biomarkers in liver cancer. Methods Mol Biol. 1238:65–76.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ren Z, Ma X, Duan Z and Chen X: Diagnosis,
therapy, and prognosis for hepatocellular carcinoma. Anal Cell
Pathol (Amst). 2020(8157406)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ronot M, Purcell Y and Vilgrain V:
Hepatocellular carcinoma: Current imaging modalities for diagnosis
and prognosis. Dig Dis Sci. 64:934–950. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Altesha MA, Ni T, Khan A, Liu K and Zheng
X: Circular RNA in cardiovascular disease. J Cell Physiol.
234:5588–5600. 2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhang X, Wang S, Wang H, Cao J, Huang X,
Chen Z, Xu P, Sun G, Xu J, Lv J and Xu Z: Circular RNA circNRIP1
acts as a microRNA-149-5p sponge to promote gastric cancer
progression via the AKT1/mTOR pathway. Mol Cancer.
18(20)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Liu Z, Zhou Y, Liang G, Ling Y, Tan W, Tan
L, Andrews R, Zhong W, Zhang X, Song E and Gong C: Circ_001783
regulates breast cancer progression via sponging miR-200c-3p. Cell
Death Dis. 10(55)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hansen TB, Kjems J and Damgaard CK:
Circular RNA and miR-7 in cancer. Cancer Res. 73:5609–5612.
2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Patop IL and Kadener S: circRNAs in
cancer. Curr Opin Genet Dev. 48:121–127. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yu T, Wang Y, Fan Y, Fang N, Wang T, Xu T
and Shu Y: CircRNAs in cancer metabolism: A review. J Hematol
Oncol. 12(90)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wei S, Zheng Y, Jiang Y, Li X, Geng J,
Shen Y, Li Q, Wang X, Zhao C, Chen Y, et al: The circRNA circPTPRA
suppresses epithelial-mesenchymal transitioning and metastasis of
NSCLC cells by sponging miR-96-5p. EBioMedicine. 44:182–193.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhong Z, Lv M and Chen J: Screening
differential circular RNA expression profiles reveals the
regulatory role of circTCF25-miR-103a-3p/miR-107-CDK6 pathway in
bladder carcinoma. Sci Rep. 6(30919)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Daoud AZ, Mulholland EJ, Cole G and
McCarthy HO: MicroRNAs in pancreatic cancer: Biomarkers,
prognostic, and therapeutic modulators. BMC Cancer.
19(1130)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Peng H, Dong JY, Zhao YN, Wu WB, Yang XL,
Chen D, Hu KF, Chen LH and Liu J: The effect of methylation level
of microRNA promoter on the expression of microRNAs and on the
proliferation, migration and invasion of lung cancer cells. Sichuan
Da Xue Xue Bao Yi Xue Ban. 50:182–187. 2019.PubMed/NCBI(In Chinese).
|
|
19
|
Lu H, Hao L, Yang H, Chen J and Liu J:
miRNA-34a suppresses colon carcinoma proliferation and induces cell
apoptosis by targeting SYT1. Int J Clin Exp Pathol. 12:2887–2897.
2019.PubMed/NCBI
|
|
20
|
Fang L, Cai J, Chen B, Wu S, Li R, Xu X,
Yang Y, Guan H, Zhu X, Zhang L, et al: Aberrantly expressed
miR-582-3p maintains lung cancer stem cell-like traits by:
Activating Wnt/β-catenin signalling. Nat Commun.
6(8640)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang S, Zou C, Tang Y, Wa Q, Peng X, Chen
X, Yang C, Ren D, Huang Y, Liao Z, et al: miR-582-3p and miR-582-5p
suppress prostate cancer metastasis to bone by repressing TGF-β
signaling. Mol Ther Nucleic Acids. 16:91–104. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang H, Dai Q, Zheng L, Yuan X, Pan S and
Deng J: Knockdown of circ_HIPK3 inhibits tumorigenesis of
hepatocellular carcinoma via the miR-582-3p/DLX2 axis. Biochem
Biophys Res Commun. 533:501–509. 2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hansen TB, Jensen TI, Clausen BH, Bramsen
JB, Finsen B, Damgaard CK and Kjems J: Natural RNA circles function
as efficient microRNA sponges. Nature. 495:384–388. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zheng Q, Bao C, Guo W, Li S, Chen J, Chen
B, Luo Y, Lyu D, Li Y, Shi G, et al: Circular RNA profiling reveals
an abundant circHIPK3 that regulates cell growth by sponging
multiple miRNAs. Nat Commun. 7(11215)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li Y, Chen B and Huang S: Identification
of circRNAs for miRNA targets by Argonaute2 RNA immunoprecipitation
and luciferase screening assays. Methods Mol Biol. 1724:209–218.
2018.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Tchakarska G and Sola B: The double
dealing of cyclin D1. Cell Cycle. 19:163–178. 2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Huang H: Matrix Metalloproteinase-9
(MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent
Advances. Sensors (Basel). 18(3249)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Couri T and Pillai A: Goals and targets
for personalized therapy for HCC. Hepatol Int. 13:125–137.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vogl TJ and Gruber-Rouh T: HCC:
Transarterial therapies-what the interventional radiologist can
offer. Dig Dis Sci. 64:959–967. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Rimassa L, Pressiani T and Merle P:
Systemic treatment options in hepatocellular carcinoma. Liver
Cancer. 8:427–446. 2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Grandhi MS, Kim AK, Ronnekleiv-Kelly SM,
Kamel IR, Ghasebeh MA and Pawlik TM: Hepatocellular carcinoma: From
diagnosis to treatment. Surg Oncol. 25:74–85. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
De Stefano F, Chacon E, Turcios L, Marti F
and Gedaly R: Novel biomarkers in hepatocellular carcinoma. Dig
Liver Dis. 50:1115–1123. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tsuchiya N, Sawada Y, Endo I, Saito K,
Uemura Y and Nakatsura T: Biomarkers for the early diagnosis of
hepatocellular carcinoma. World J Gastroenterol. 21:10573–10583.
2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lei M, Zheng G, Ning Q, Zheng J and Dong
D: Translation and functional roles of circular RNAs in human
cancer. Mol Cancer. 19(30)2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Qiu L, Xu H, Ji M, Shang D, Lu Z, Wu Y, Tu
Z and Liu H: Circular RNAs in hepatocellular carcinoma: Biomarkers,
functions and mechanisms. Life Sci. 31(116660)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu X, Zhong Y, Li J and Shan A: Circular
RNA circ-NT5C2 acts as an oncogene in osteosarcoma proliferation
and metastasis through targeting miR-448. Oncotarget.
8:114829–114838. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
He Q, Huang L, Yan D, Bi J, Yang M, Huang
J and Lin T: CircPTPRA acts as a tumor suppressor in bladder cancer
by sponging miR-636 and up-regulating KLF9. Aging (Albany NY).
11:11314–11328. 2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lee YS and Dutta A: MicroRNAs in cancer.
Annu Rev Pathol. 4:199–227. 2009.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yuan W, Peng S, Wang J, Wei C, Ye Z, Wang
Y, Wang M, Xu H, Jiang S, Sun D, et al: Identification and
characterization of circRNAs as competing endogenous RNAs for
miRNA-mRNA in colorectal cancer. PeerJ. 7(e7602)2019.PubMed/NCBI View Article : Google Scholar
|
|
42
|
He J, Su X and Xie W: MiR-582-3p
alleviates osteoarthritis progression by targeting YAP1. Mol
Immunol. 128:258–267. 2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Xu J, Zhang Y, Huang Y, Dong X, Xiang Z,
Zou J, Wu L and Lu W: circEYA1 functions as a sponge of miR-582-3p
to suppress cervical adenocarcinoma tumorigenesis via up-regulating
CXCL14. Mol Ther Nucleic Acids. 22:1176–1190. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang J, He H, Jiang Q, Wang Y and Jia S:
CBX6 promotes HCC metastasis via transcription factors
snail/zeb1-mediated EMT mechanism. Onco Targets Ther.
13:12489–12500. 2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Goldar S, Khaniani MS, Derakhshan SM and
Baradaran B: Molecular mechanisms of apoptosis and roles in cancer
development and treatment. Asian Pac J Cancer Prev. 16:2129–2144.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Amidfar M, Karami Z, Kheirabadi GR, Afshar
H and Esmaeili A: Expression of Bcl-2 and Bax genes in peripheral
blood lymphocytes of depressed and nondepressed individuals. J Res
Med Sci. 24(41)2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kristensen LS, Hansen TB, Venø MT and
Kjems J: Circular RNAs in cancer: Opportunities and challenges in
the field. Oncogene. 37:555–565. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Huang M, He YR, Liang LC, Huang Q and Zhu
ZQ: Circular RNA hsa_circ_0000745 may serve as a diagnostic marker
for gastric cancer. World J Gastroenterol. 23:6330–6338.
2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Jiao J, Zhang T, Jiao X, Huang T, Zhao L,
Ma D and Cui B: hsa_circ_0000745 promotes cervical cancer by
increasing cell proliferation, migration, and invasion. J Cell
Physiol. 235:1287–1295. 2020.PubMed/NCBI View Article : Google Scholar
|
